Harbright Ventures

Emerging manager

Built from this firm's Form D filings. The firm files no SEC adviser report.

Website: https://harbrightventures.com
HQ: NC

Harbright Ventures invests in disruptive innovation that positively impacts people and the planet. Its portfolio spans health, climate, manufacturing, water, and software companies. The firm is led by founding partners John Leachman and John Michael Harlow, and includes Dr. Emily Blum as Chief Medical Officer and Andy Kintz as Strategic Advisor.

01 · Says / Does

Tag	Says	Does
Stages	Not stated	Not enough dated deals
Sectors	Enterprise SaaS, Digital health, Medical devices, Climate hardware, Manufacturing	Not enough dated deals
Regions	Not stated	Not enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

Fund	Year	Size	Status
Harbright Ventures II, LP /NC Harbright Ventures invests in early-stage companies pursuing disruptive innovation that positively impacts people and the planet. Its portfolio spans medicine, clean technology, and software that makes businesses more productive and efficient. Inferred from the firm's website and portfolio companies	2022	$850K to $20M (Form D)	Open, writing first checks

03 · People across funds

John Harlow
Harbright Ventures II, LP /NC (Named on Form D)
John Leachman, Founder and Partner
Harbright Ventures II, LP /NC (Named on Form D)
Robert Ross
Harbright Ventures II, LP /NC (Named on Form D)
Andy Kintz, Strategic Advisor
Harbright Ventures II, LP /NC (Team)
Dr. Emily Blum, Chief Medical Officer
Harbright Ventures II, LP /NC (Team)
John Michael Harlow, Founder and Partner
Harbright Ventures II, LP /NC (Team)

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026